No Ganja Deficiency in the Medical Cannabis Industry – CLA


KINGSTON, Jamaica – The Cannabis Licensing Authority (CLA) states that it is not aware of any deficiency affecting the locally regulated medical cannabis industry.

This, according to the authority, follows media reports of a ganja deficiency on the island.

According to Faith Graham, acting Senior Director of Operations, the agency routinely monitors licensees’ ganja inventory through the Enforcement and Monitoring Department and there is no evidence of a shortage of ganja within the regulated space.

“There was no such report from CLA licensees, and reviews conducted with licensees confirmed that there was no shortage,” she said.

The agency assured the public that there is currently no cause for concern about the availability of cannabis for medical, scientific and therapeutic purposes.

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available at home or at work and corresponds to the printed version at